Using a blend of computer modeling, structural and cell-based studies, scientists at The Wertheim UF Scripps Institute have ...
Company believes that data from sunRIZE and the Expanded Access Program (EAP) provide evidence of activity of ersodetug in ...
Combination of AT7687 and cagrilintide demonstrated enhanced weight loss effect in obese, insulin-resistant, pre-diabetic non-human primate (NHP) ...
Morgan Stanley, Leerink Partners, Cantor and Wells Fargo Securities acted as joint book-running managers for the offering.
Explore the effects of Propofol and insulin on cognitive function after surgery, especially in older adults with memory impairment.
In men with type 1 diabetes, intravenous glucose-dependent insulinotropic polypeptide can reduce postprandial plasma glucose ...
Examination of transdermal berberine delivery, GLP-1 pathway terminology in supplement marketing, and consumer evaluation ...
Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) ("Amylyx" or the "Company") today announced the selection of AMX0318, a long-acting glucagon-like peptide-1 (GLP-1) receptor antagonist, as a development ...
Health system pharmacists and clinicians are monitoring a wave of drug approvals expected throughout 2026, including first-in-class therapies and expanded uses of existing drugs with implications for ...
Over 27 percent of adults worldwide with obesity qualify for GLP-1 weight loss medicines but access remains unequal.
News-Medical.Net on MSN
Simple drug treatments could help older brains cope with memory decline and postoperative recovery
Simple pharmaceutical interventions could help older brains cope with memory impairment and recovery after surgery, new ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback